Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344812 · ClinicalTrials.gov registry record · Phase 2
Opioid Maintenance Medications Comparison Study
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 220
- Enrollment target
NCT00344812: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT00344812 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00344812, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 220 participants
- Enrollment target
Study Summary
A 17 week, double-blind, randomized, parallel group, four arm design outpatient study comparing LAAM, buprenorphine and two dose levels of methadone for the treatment of opioid dependence.
Interventions
- DRUG LAAM. buprenorphine and methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 1996-01 |
| Est. Completion | 1998-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00344812
The ClinicalTrials.gov registry entry for NCT00344812 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LAAM. buprenorphine and methadone is the first listed.
NCT00344812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00344812 about?
NCT00344812 is a clinical study titled "Opioid Maintenance Medications Comparison Study". A 17 week, double-blind, randomized, parallel group, four arm design outpatient study comparing LAAM, buprenorphine and two dose levels of methadone for the treatment of opioid dependence.
What is the current status of trial NCT00344812?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 220 participants. The study started on 1996-01. Estimated completion is 1998-06.
What interventions are being tested in trial NCT00344812?
The interventions under investigation include: LAAM. buprenorphine and methadone (DRUG).
Who is sponsoring clinical trial NCT00344812?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.